Once-daily treatment for canine atopic dermatitis
Delivers 6-in-1 parasite protection for cats
Valuable discounts, expert information, and tips
See how injectable medications offer value beyond the prescription
The first and only FDA-Approved veterinary antiemetic
The first long-lasting monoclonal antibody therapy for canine atopic dermatitis
Vaccination for the prevention of respiratory disease caused by BRSV
The beef industry’s No. 1 branded preconditioning program
Exclusive pricing program for Cattle producers
Outstanding protection against costly respiratory and reproductive diseases
Treatment and control of gastrointestinal roundworms, lungworms, eyeworms, grubs, sucking lice and mange mites
Innovative food safety products that help deliver a farm-to-fork solution for beef
The most comprehensive guarantee available
First and only FDA-approved antibiotic for horses that offers a full course of therapy in just two doses
Annual vaccination with CORE EQ INNOVATOR helps provide the protection your horse needs
Treats and controls encysted small strongyles, bots and roundworms. QUEST PLUS contains an additional active ingredient for efficacy against tapeworms
Patented and scientific method of determining fair service pricing to improve your clinic's profitability
Connect directly to valuable dairy management resources and experts
The most "veterinarian recommended" and "producer used" prostaglandin in the market
Delivers the peace of mind and profitability that come with no milk discard
Effective and convenient treatment for acute metritis in cattle
Working together to improve reproduction
One injection treats and controls swine respiratory disease for 7 days
Protect sows and gilts from costly breeding herd diseases — parvovirus, leptospirosis and erysipelas
The industry standard for in ovo technology.
Full automation solutions for hatchery automation
Prevention and control of necrotic enteritis, increased rate of weight gain and improved feed efficiency in poultry
for the prevention of coccidiosis in poultry
modified-live vaccine that helps poultry companies reduce their overall Salmonella load
Blood glucose monitoring system
Smart new diagnostics platform that can reinvent your in-house diagnostic routines
Detect Johne’s Disease with confidence in cattle and goat herds
Simple and effective detection of a deadly Feline Virus
Accurate, affordable and easy to use
Order Beef Genetics products online
Order Dairy Genetics products online
Delivers reliable predictions of genetic merit based on test results of core traits
Represents the latest advancement in Angus genotyping technology.
Register today to learn more
Become a more effective leader
Looking for a tailored experience?
Earn continuing education credits and stay current on industry developments with Zoetis’ convenient, on-demand learning solutions.
Veterinarians, Veterinarian Techs, Business Owners, and Farm Hands
Launch your veterinary career
Veterinarian Students and Recent Graduates
Animal health expertise and results-focused resources for high-performing teams and leaders.
Veterinarians, Dairy producers, Beef producers, Equine Specialists, Pork producers, Poultry producers, Managers, Business Owners and Staff
Home / NEWS & MEDIA / Zoetis Appoints Dr. Richard E. Goldstein as Executive Director and Chief Medical Officer of U.S. Diagnostics
Internationally-recognized veterinarian, author and teacher brings unique passion and innovation to the Diagnostics Team
PARSIPPANY, NJ – Jan. 8, 2018 – Zoetis today announced the appointment of Richard E. Goldstein, DVM, DACVIM, DECVIM-CA to the position of Executive Director and Chief Medical Officer of U.S. Diagnostics, effective February 5, 2018. Dr. Goldstein will lead the U.S. Diagnostics team in expanding its product portfolio and will spearhead the division’s studies and publishing opportunities.
“Dr. Goldstein is a well-respected, internationally-renowned veterinarian in small animal internal medicine and we’re honored to have him join our Zoetis team,” Lisa Lee, vice president, U.S. Diagnostics and Business Solutions at Zoetis. “His award-winning work, research and passion for preventing genetic and infectious diseases make him an ideal fit for our company as we continue to develop innovative technologies and solutions to diagnose disease as well as treat and improve the lives of pets.”
In his role at Zoetis, Dr. Goldstein will work closely with the U.S. Companion Animal Division to develop educational events for sales and marketing, while leading efforts to bring the company’s unique “Predict, Prevent, Detect and Treat” strategy to life. He will also manage the Key Opinion Leader program. Dr. Goldstein and the team will continue to emphasize digital innovation, diagnostics, genetic tests, and biodevices as important tools to help veterinarians make better healthcare decisions informed by data. “I’ve always been incredibly impressed with Zoetis and its industry-leading approach to improving overall animal health,” said Dr. Goldstein. “I am excited and energized about taking on this new role, and I look forward to continuing the Diagnostics team mission to stay on the cutting edge of technology and novel concepts to fight genetic and infectious diseases in pets.”
Prior to joining Zoetis, Dr. Goldstein spent 12 years as a Professor of Small Animal Medicine at the Cornell University College of Veterinary Medicine and the last six years as the Chief Medical Officer of the nationally renowned Animal Medical Center in New York City.
Dr. Goldstein received his B.S. degree from the Institute of Biological Sciences, Hebrew University of Jerusalem, and his DVM from Koret School of Veterinary Medicine, Hebrew University of Jerusalem. He is board certified in Small Animal Internal Medicine by both the American College of Veterinary Internal Medicine and the European College of Veterinary Internal Medicine, Companion Animals.
Dr. Goldstein is the recipient of several prestigious awards, including the American College of Veterinary Internal Medicine, Endocrinology Society Research Award and the Norden Distinguished Teaching Award. His research and clinical interests throughout his career have been focused on improving the ability of veterinarians to detect and prevent genetic and infectious diseases in companion animals through the development of multiple novel diagnostic tests and vaccines. His most significant impact has been in infectious disease through his work on both canine Lyme disease and leptospirosis, for which he has achieved international recognition. Dr. Goldstein is active in the One Health community and serves on the scientific advisory boards of the One Health Commission, as well as the Global Lyme Alliance.
About ZoetisZoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products, genetic tests, biodevices and a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2016, the company generated annual revenue of $4.9 billion with approximately 9,000 employees. For more information, visit www.zoetis.com.
For further information contact:Colleen T. White973.email@example.com
Danielle Paleafico firstname.lastname@example.org
Mon–Fri, 8am–8pm ET
You are leaving the country website to access another site in the group.
Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.
This site is intended for U.S. Animal Healthcare Professionals.
All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2017 Zoetis Services LLC. All rights reserved.